ID1 and cancer: For this reason, the phage display technology was chosen to isolate human anti-Id scFv fragments from the synthetic ETH-2 library (Pini et al, 1998) since (i) such scFv do not need further engineering and (ii) they could be used for repeated immunisations of cancer patients without invoking a human anti-mouse antibody response.